medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2009, Number 587

<< Back Next >>

Rev Med Cos Cen 2009; 66 (587)

Aspergilosis pulmonar

Sanabria FS

Language: Spanish
References: 20
Page: 67-71
PDF size: 219.48 Kb.


ABSTRACT

Aspergillus is a ubiquitous fungus that causes a variety of clinical syndromes in the lung. These entities differ clinically, radiologically, immunologically, and in their response to various therapeutic agents. It is essential for clinicians to be familiar with the clinical presentation, diagnostic methods, and approach to management of the spectrum of pulmonary aspergillosis to reduce the high morbidity and mortality caused by aspergillus-related syndromes.


REFERENCES

  1. 1.Agarwal R et al. Allergic Bronchopulmonary Aspergillosis: Lessons from 126 patients attending a Chest Clinic in North India. Chest 2006; 130: 442-448.

  2. Camuset J et al. Treatment of Chronic Pulmonary Aspergillosis by Voriconazole in Noninmunocompromised Patients. Chest 2007; 131: 1435-1441

  3. Chamilos G, Kontoyiannis D. Defining the diagnosis of invasive aspergillosis. Medical Mycology 2006; 44: S163-S172

  4. Greene R et al. Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign. Clinical Infectious Diseases 2007; 44: 373-379

  5. Herbrecht R et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. The New England Journal of Medicine 2002; 347: 408-415

  6. Hope W et al. Laboratoty diagnosis of invasive aspergillosis. Lancet Infectious Diseases 2005; 5: 609-622

  7. Kumar R. Mild, Moderate and Severe Forms of Allergic Bronchopulmonary Aspergillosis: A Clinical and Serologic Evaluation. CHEST 2003: 124: 890-892

  8. Lumbreras C, Gavald J. Aspergilosis invasora: manifestaciones clínicas y tratamiento. Revista Iberoamericana de Micología 2003; 20: 79-89

  9. Mastella G et al. Allergic brochopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. European Respiratory Journal 2000; 16: 464-471

  10. Saballs P et al. Tratamiento de la aspergilosis invasiva. Revista Iberoamericana de Micología 2000; 17: S93-S96

  11. Sabillón N et al. Aspergilosis Invasiva: Reporte de un caso y revisión de literatura. Revista Médica Hondureña 2006; 74: 201-204

  12. Segal B and Walsh T. Current Approaches to Diagnosis and Treatment of Invasive Aspergillosis. American Journal of Respiratory and Critical Care Medicine 2006; 173: 707-717

  13. Sharma O, Chwogule R. Many faces of pulmonary aspergillosis. European Respiratory Journal 1998; 12: 705-715

  14. Soubani A, Chandrasekar P. The Clinical Spectrum of Pulmonary Aspergillosis. Chest 2002; 121:1988-1999

  15. Stergiopoulou T, et al. Host- Dependient Patters of Tissue Injury in Invasive Pulmonary Aspergillosis. American Journal of Clinical Pathology 2007: 127:349-355

  16. Vaideeswar P et al. Invasive pulmonary aspergillosis: A study of 39 cases at autopsy. Journal Posgrad Medicine 2004; 50: 21-26

  17. Wallace J et al. Risk Factors and Outcomes Associated with Identification of Aspergillus in Respiratory Specimens from Persons with HIV Disease. Chest 1998; 114: 131-137

  18. Warnock D. Trends in the Epidemiology of Invasive Fungal Infecions. Jpn Journal Medical of Mycology 2007; 48: 1-12

  19. Zhang X et al. Aspergillus pneumonia in renal transplant recipients. Chinese Medical Journal 2008; 121 (9): 791-794

  20. Zmeili O, Soubani A. Pulmonary aspergillosis: a clinical update. Q J Med 2007; 100:317-334




2020     |     www.medigraphic.com